http://www.mmm-online.com/label/topic/218/ Articles tagged with Label from Medical Marketing and Media MMM mmmsubs@haymarketmedia.com no The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer. http://www.mmm-online.com/fda-gut-checks-dtc-clarity/article/293327/ Tue, 14 May 2013 17:50:23 GMT The new survey will study whether patients understand how efficacy is calculated and experiment with ways to make communications clearer. MMM The FDA approval of 23-mg donepezil (Aricept) conflicted with the opinions of its own reviewers and breached the agency's own regulatory standard, authors write in a BMJ article, leading to misleading consumer and physician ad campaigns that put patients at risk. http://www.mmm-online.com/journal-article-targets-fda-misstep-on-aricept/article/233282/ Thu, 22 Mar 2012 19:07:20 GMT The FDA approval of 23-mg donepezil (Aricept) conflicted with the opinions of its own reviewers and breached the agency's own regulatory standard, authors write in a BMJ article, leading to misleading consumer and physician ad campaigns that put patients at risk. MMM Johnson & Johnson/Bayer's Xarelto (rivaroxaban) received FDA approval for stroke prevention in atrial fibrillation (SPAF), the second novel anticoagulant to gain US marketing approval for SPAF. http://www.mmm-online.com/company-news-jj-bayer-and-siemens-healthcare/article/216280/ Tue, 08 Nov 2011 16:58:22 GMT Johnson & Johnson/Bayer's Xarelto (rivaroxaban) received FDA approval for stroke prevention in atrial fibrillation (SPAF), the second novel anticoagulant to gain US marketing approval for SPAF. MMM The Supreme Court struck a blow to FDA pre-emption of state laws with a 6-3 decision in Wyeth v. Levine finding the company liable for a failure-to-warn claim under Vermont state law. http://www.mmm-online.com/supremes-deny-wyeth-in-pre-emption-bid/article/128265/ Wed, 04 Mar 2009 18:38:37 GMT The Supreme Court struck a blow to FDA pre-emption of state laws with a 6-3 decision in Wyeth v. Levine finding the company liable for a failure-to-warn claim under Vermont state law. MMM Monthly Prescribing Reference (MPR) has relaunched its website with a number of enhancements to functionality and design, as well as a new, easier-to-remember URL, www.eMPR.com. http://www.mmm-online.com/mpr-rolls-out-revamped-website/article/126092/ Tue, 20 Jan 2009 13:44:44 GMT Monthly Prescribing Reference (MPR) has relaunched its website with a number of enhancements to functionality and design, as well as a new, easier-to-remember URL, www.eMPR.com. MMM Career staffers at the FDA objected to new drug labeling regulations that favor pre-emption of state liability lawsuits, according to a report from Rep. Henry Waxman's Committee on Oversight and Government Reform. http://www.mmm-online.com/waxman-fda-career-staff-objected-to-preemption-policies/article/120256/ Fri, 31 Oct 2008 19:18:01 GMT Career staffers at the FDA objected to new drug labeling regulations that favor pre-emption of state liability lawsuits, according to a report from Rep. Henry Waxman's Committee on Oversight and Government Reform. MMM FDA will initiate a pilot project to help manufacturers choose safer proprietary drug names. http://www.mmm-online.com/fda-to-launch-drug-name-review-pilot-project/article/119208/ Wed, 08 Oct 2008 15:40:35 GMT FDA will initiate a pilot project to help manufacturers choose safer proprietary drug names. MMM The FDA on Wednesday announced it is proposing revisions to physician labeling for Rx drugs to include more info about their use by pregnant and/or breast-feeding mothers. http://www.mmm-online.com/fda-proposes-rx-label-revisions-for-moms/article/110649/ Thu, 29 May 2008 15:00:00 GMT The FDA on Wednesday announced it is proposing revisions to physician labeling for Rx drugs to include more info about their use by pregnant and/or breast-feeding mothers. MMM King Pharmaceuticals will cut 20% of its 2,600 employee workforce after a federal appeals court judge ruled against a patent extension on the company's blood pressure treatment Altace. http://www.mmm-online.com/king-reduces-workforce-by-20-cuts-mostly-sales-jobs/article/58133/ Mon, 22 Oct 2007 04:00:00 GMT King Pharmaceuticals will cut 20% of its 2,600 employee workforce after a federal appeals court judge ruled against a patent extension on the company's blood pressure treatment Altace. MMM With reimbursement limits the latest threat to its anemia franchise, Amgen moved to shore up investor confidence yesterday. http://www.mmm-online.com/amgen-seeks-to-ease-investor-concerns-as-staff-cuts-loom/article/30063/ Tue, 21 Aug 2007 04:00:00 GMT With reimbursement limits the latest threat to its anemia franchise, Amgen moved to shore up investor confidence yesterday. MMM